Sponsoring the Targeted Cancer Therapy World Congress 2010 is a time and cost-effective opportunity to develop existing and new business.
Sponsorship packages offer your company thought-leadership positioning, branding, and the opportunity to set up face-to-face meetings with hundreds of decision makers from your target market in just 3 working days.
By background, Myriam Zylberman is a general psychiatrist who is also trained in clinical pharmacology and biostatistics. After one year as an International Project Manager at Servier Company in the Neurosciences Medical Department, she joined the French affiliate of Eli Lilly and company in 1990 as a Clinical Research Physician for Prozac. Further on she has been responsible for Clinical Research in Neurosciences made at the French affiliate level of the company.
After 10 years in the medical department, she was promoted to Director of Pricing Reimbursement Access and New Products where she covers the overall portfolio of Lilly drugs. She has been promoted to the position of member of the Executive Team of the Affiliate in 2006 and is part of different professional associations.
Appearing:
DAY 2 WEDNESDAY 22 SEPTEMBER – IMPROVING PRE-CLINICAL & EARLY DEVELOPMENT
12.40pm
Case study: a complex immunohistochemical, molecular, and FISH analysis to guide therapy for non-small cell lung adenocarcinoma
What are the options for a pathologist using immunohistochmical and molecular tests to select appropriate drugs for first line chemotherapy?
What are the options for a pathologist using an algorithmic array of molecular tests to detect targets for appropriate second line biological therapy?
Future approaches to refine and expand predictive analysis of non-small lung adenocarcinoma – what is required from the perspective of a pathologist?
Sponsoring Targeted Cancer
Therapy World Congress 2010
is a time and cost-effective opportunity to develop
existing and new business.
Sponsorship packages offer your company thought-leadership positioning, branding, and the opportunity to set up face-to-face meetings with hundreds of decision makers from your target market in just 3 working days.
